Crest Nicholson shares plummet amid profit warning
Housebuilder, Crest, has failed to exploit a benign backdrop in recent years. Should it now merge with rival Bellway? Matthew Partridge reports
Shares in homebuilder Crest Nicholson fell by 11% last Thursday after the company unveiled yet another profit warning, says Melissa Lawford in The Telegraph. But they clawed back most of the lost ground a day later after Crest’s new CEO Martyn Clark said it had turned down an unsolicited £650 million takeover bid from rival Bellway that “significantly undervalued” the business.
However, experts warned that Crest’s recent poor performance means that Clark “will face a difficult turnaround job. Shareholders may have wished management had asked their opinion” before rejecting the bid. Even though Bellway’s all-share offer works out at a 30% premium over Crest’s share price in May, Clark clearly thinks that this is too little, says Joshua Oliver in the Financial Times.
His main concern is that it would value the company at a discount to what he considers to be its “strong land portfolio”. Still, Clark may be too optimistic about Crest’s prospects as a standalone company. It has “struggled, even in the context of widespread gloom in the homebuilding sector”, thanks to “building defects at older sites and buyers put off by high mortgage costs”.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
How is Crest performing?
Crest’s past “prowess at making a horlicks of a market ostensibly loaded in its favour” is dragging down its share price, says Alistair Osborne in The Times. There is also the promise of “more nasties to come” over past problems with cladding and the risk of fire.
Some brokers argue that a merger with Bellway would produce “at least £25 million of synergies” and facilitate the purchase of larger sites. With the top 25 investors in Crest also owning 36% of Bellway, Clark “has a job on proving that a home-alone strategy works best for Crest”.
Already, it seems that some of Crest Nicholson’s biggest shareholders are “pushing” the board to agree some sort of tie-up with Bellway, says Sam Chambers in The Sunday Times. For example, asset management group Schroders, which owns 3% stakes in both companies, is sceptical about the odds of Crest managing to turn itself around as a separate company. It thinks that “the time has come” for Crest “to become part of a larger group”.
Similarly, asset manager abrdn, which also has both companies in its UK Value Equity Fund portfolio, thinks that neither Crest’s board or its shareholders can deny that “there is logic to a combination with Bellway”, though it believes that Bellway’s bid “is not at an appropriate price”.
While Crest’s shareholders may think that Bellway certainly has “scope to offer more” for Crest, it may only require a “nominal hike” to get the deal over the line, says Yawen Chen on Breakingviews.
What’s more, consolidation not only “makes sense for Crest in particular but also for UK builders in general”. Previously “chunky” returns on capital employed “have slumped to single-digit levels”, thanks to “cost inflation and a housing market wrestling with higher interest rates that make it harder for buyers to take the plunge”.
This article was first published in MoneyWeek's magazine. Enjoy exclusive early access to news, opinion and analysis from our team of financial experts with a MoneyWeek subscription.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Investors pull money from UK equities as government warns of “painful” Budget
The government’s post-election honeymoon period has been short-lived, and investors are shying away from UK equities as a result
By Katie Williams Published
-
Top global fintech companies to invest in
One British fintech hogs the headlines, but there are two top performers in the US. We explain where you should put your money
By David C. Stevenson Published
-
Qualcomm could acquire rival Intel – but securing the deal won't be easy
A tie-up between Qualcomm and its semiconductor rival Intel would be a coup. But multiple regulatory and commercial hurdles lie ahead.
By Dr Matthew Partridge Published
-
Modi’s reforms set Indian stocks on fire
Indian stocks pass a new milestone, but global fund managers are holding back. Are there signs of overheating?
By Alex Rankine Published
-
How to invest in the quiet market months
Here's how to invest in the quiet market months, since “sell in May” hasn’t paid off this year.
By Cris Sholto Heaton Published
-
Spire Healthcare: invest in the booming demand for private healthcare
Spire Healthcare is one of the few listed companies benefiting from the growing trend in private healthcare. Should you invest?
By Rupert Hargreaves Published
-
Are insurance companies a good investment?
Costs may be soaring but the insurance sector is currently going through one of its most profitable periods. The market has been slow to realise the opportunity here
By Rupert Hargreaves Published
-
Dr Martens shares slump: should you give it the boot?
Over the past three years, Dr Martens has fallen out of fashion. Are the shares worth a look?
By Jamie Ward Published
-
Google's legal challenges – could it be broken up?
Google is fending off legal challenges from both the EU and the US. But would breaking it up actually work?
By Dr Matthew Partridge Published
-
Fast-growing bargain stocks the market has missed
A professional investor recommends attractive stocks to invest in. This week: Dan Higgins, portfolio manager, Majedie Investments, highlights three favourites
By Dan Higgins Published